 Experimental hepatocellular carcinoma MR receptor Relaxation time measurements magnetic resonance MR imaging different animal models hepatocellular carcinoma HCC intravenous administration asialoglycoprotein-directed arabinogalactan-stabilized ultrasmall superparamagnetic iron oxide mumol Fe/kg receptor agent normal liver msec msec rats HCC normal liver liver chronic hepatitis unchanged results similar administration reticuloendothelial cell-directed conventional iron oxide required dose receptor agent MR woodchuck model HCC distribution hepatocyte-directed agent regions functioning differentiated hepatocytes tumor tissue results MR receptor imaging role differentiation primary liver tumor functional liver tissue normal liver hepatitis regenerating nodules